Simulations Plus Stock
Price
Target price
-
-
-
-
-
?31.17
WKN: 924294 / Symbol: SLP / Name: Simulations Plus / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Simulations Plus Stock
With 11 Buy predictions and not the single Sell prediction the community is currently very high on Simulations Plus.
However, we have a potential of -8.82% for Simulations Plus as the target price of 31 € is below the current price of 34.0 €.
Pros and Cons of Simulations Plus in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Simulations Plus vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Simulations Plus | - | - | - | - | - | - | - |
| MicroVision Inc | 0.060% | -2.597% | -15.286% | -6.606% | -48.730% | -71.311% | -64.495% |
| Fonar Corp. New | 0.810% | 3.333% | -2.362% | -17.333% | -12.676% | -25.749% | -23.457% |
| Fluidigm Corp. | 0.830% | -4.000% | 25.654% | -27.273% | -29.825% | -5.882% | -77.290% |
Comments
Simulations Plus (NASDAQ:SLP) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Show more
Ratings data for SLP provided by MarketBeat
Simulations Plus, Inc. (NASDAQ: SLP) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for SLP provided by MarketBeat
Simulations Plus, Inc. (NASDAQ: SLP) had its price target lowered by analysts at Stephens from $28.00 to $20.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for SLP provided by MarketBeat
News
Simulations Plus Invests in Clinical Development Technology Company Nurocor
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical
